Technical Analysis for SURF - Surface Oncology, Inc.

Grade Last Price % Change Price Change
D 7.84 4.39% 0.33
SURF closed up 3.59 percent on Thursday, May 6, 2021, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical SURF trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 4.39%
Pocket Pivot Bullish Swing Setup 4.39%
Bollinger Band Squeeze Range Contraction 4.39%
Stochastic Reached Overbought Strength 4.39%
Weak + Overbought Other 4.39%
Overbought Stochastic Strength 4.39%
Crossed Above 20 DMA Bullish 8.14%
Pocket Pivot Bullish Swing Setup 8.14%
Bollinger Band Squeeze Range Contraction 8.14%
BB Squeeze Started Range Contraction 8.14%
Older End-of-Day Signals for SURF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Resistance about 1 hour ago
Possible Pocket Pivot about 2 hours ago
Up 1 ATR about 2 hours ago
Rose Above 50 DMA about 3 hours ago
10 DMA Support about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Surface Oncology is a clinical-stage immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment with lead programs targeting CD47 and CD73. Surface’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response, alone or in combination with other therapies. The company has a pipeline of immunotherapies and a strategic collaboration with Novartis focused on up to three next-generation cancer immunotherapies.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunotherapy Cancer Immunotherapy Cancer Treatments Virotherapy Tumor Immunotherapies Novel Cancer Cancer Research Cd73 CD47 Active Immunotherapy Tumor Microenvironment

Is SURF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.38
52 Week Low 2.4
Average Volume 1,566,503
200-Day Moving Average 8.29
50-Day Moving Average 7.90
20-Day Moving Average 7.15
10-Day Moving Average 7.28
Average True Range 0.53
ADX 18.62
+DI 16.96
-DI 19.44
Chandelier Exit (Long, 3 ATRs ) 6.76
Chandelier Exit (Short, 3 ATRs ) 7.85
Upper Bollinger Band 7.84
Lower Bollinger Band 6.45
Percent B (%b) 0.76
BandWidth 19.50
MACD Line -0.20
MACD Signal Line -0.31
MACD Histogram 0.1061
Fundamentals Value
Market Cap 305.48 Million
Num Shares 40.7 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -5.66
Price-to-Sales 6.80
Price-to-Book 3.88
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.35
Resistance 3 (R3) 8.26 7.89 8.21
Resistance 2 (R2) 7.89 7.68 7.94 8.16
Resistance 1 (R1) 7.70 7.54 7.80 7.79 8.12
Pivot Point 7.33 7.33 7.38 7.38 7.33
Support 1 (S1) 7.14 7.12 7.24 7.23 6.90
Support 2 (S2) 6.77 6.98 6.82 6.86
Support 3 (S3) 6.58 6.77 6.81
Support 4 (S4) 6.67